With further understanding of clinical, radiological, and immunological characteristics of neuromyelitis optica spectrum disorder (NMOSD), especially aquaporin‐4 (AQP4) antibody, NMOSD as an independent central nervous system disease has attracted more and more attention (Lennon et al., 2004). The gene discussed is AQP4; the disease is neuromyelitis optica.